Feedback / Questions
Jakafi (ruxolitinib) - Incyte
pelabresib (DAK539) - Novartis
http://clinicaltrials.gov/ct2/show/NCT07340138
Sep 10, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next